Livermore

Knowles Julius

SEC CIK
0001808365

Latest role at each company

Trades

Every Form 4 that lists Knowles Julius as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
KROSKeros Therapeutics, Inc.Jun 8, 2026Jun 4, 2026Knowles JuliusDirectorSSaleCommon Stock−2.63K$10.73−$28.17K10.96K−19.3%SEC10b5-1
KROSKeros Therapeutics, Inc.Jan 20, 2023Apr 13, 2020Knowles JuliusDirectorPPurchaseCommon Stock+1.19K$20.98+$24.99K1.19KNew positionSEC
KROSKeros Therapeutics, Inc.Jan 5, 2022Jan 3 – Jan 5, 2022Knowles JuliusDirectorSSaleCommon Stock−47.65K$57.8396−$2.76M232.73K−17.0%SEC
KROSKeros Therapeutics, Inc.Dec 3, 2021Dec 1 – Dec 2, 2021Knowles JuliusDirectorSSaleCommon Stock−47.65K$54.0886−$2.58M251.54K−15.9%SEC
KROSKeros Therapeutics, Inc.Nov 3, 2021Nov 1 – Nov 3, 2021Knowles JuliusDirectorSSaleCommon Stock−47.65K$42.1215−$2.01M270.35K−15.0%SEC
KROSKeros Therapeutics, Inc.Oct 21, 2021Oct 19 – Oct 20, 2021Knowles JuliusDirectorSSaleCommon Stock−8.6K$38.1997−$328.44K289.16K−2.9%SEC
KROSKeros Therapeutics, Inc.Oct 18, 2021Oct 14 – Oct 18, 2021Knowles JuliusDirectorSSaleCommon Stock−26.37K$38.5578−$1.02M292.55K−8.3%SEC
KROSKeros Therapeutics, Inc.Oct 5, 2021Oct 1 – Oct 5, 2021Knowles JuliusDirectorSSaleCommon Stock−12.69K$40.1037−$508.75K302.96K−4.0%SEC
KROSKeros Therapeutics, Inc.Sep 29, 2021Sep 27, 2021Knowles JuliusDirectorSSaleCommon Stock−95.3K$41.1744−$3.92M307.97K−23.6%SEC
KROSKeros Therapeutics, Inc.Jul 6, 2021Jul 1 – Jul 2, 2021Knowles JuliusDirectorSSaleCommon Stock−47.65K$41.3068−$1.97M345.59K−12.1%SEC